Cited by 6Genetic and Kidney Cyst DiseasesCystic Fibrosis Research AdvancesGenomics and Rare Diseases

Ciliopathy-Associated Missense Mutations in IFT140 are Tolerated by the Inherent Resilience of the IFT Machinery

Open access
Beyer, Tina, Diwan, Gaurav D., Leonhard, Tobias, Dahlke, Katrin, Klose, Franziska, Stehle, Isabel F., Seda, Marian, Bolz, Sylvia +5 more·2025·Molecular & Cellular Proteomics

Published version of a preprint

Abstract

Genotype-phenotype correlations of rare diseases are complicated by low patient number, high phenotype variability, and compound heterozygosity. Mutations may cause instability of single proteins, and affect protein complex formation or overall robustness of a specific process in a given cell. Ciliopathies offer an interesting case for studying genotype-phenotype correlations as they have a spectrum of severity and include diverse phenotypes depending on different mutations in the same protein. For instance, mutations in the intraflagellar transport protein IFT140 cause a vast spectrum of ciliopathies ranging from isolated retinal dystrophy to severe skeletal abnormalities and multi-organ diseases such as Mainzer-Saldino and Jeune syndrome. Here, the quantitative effects of 23 missense mutations in IFT140, which forms part of the crucial IFT-A complex of the ciliary machinery, were analyzed using affinity purification coupled with mass spectrometry (AP-MS). A subset of 10 mutations led to a significant and domain-specific reduction in IFT140-IFT-A complex interaction indicating complex formation issues and potentially hampering its molecular function. Knockout of IFT140 led to loss of cilia, as shown before. However, phenotypically only mild effects concerning cilia assembly were observed for two out of four tested IFT140 missense mutations. Therefore, our results demonstrate the utility of AP-MS in discerning pathogenic MMs from polymorphisms, and we postulate that reduced function is tolerated by the evolutionarily highly conserved IFT-A system.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mcpro.2025.100916

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Beyer, T., Diwan, G. D., Leonhard, T., Dahlke, K., Klose, F., Stehle, I. F., Seda, M., Bolz, S., Woerz, F., Russell, R. B., Jenkins, D., Ueffing, M., & Boldt, K.
Affiliations
  • University of Tübingen (DE)
  • Heidelberg University (DE)
  • University College London (GB)
Corresponding author
  • Beyer, Tina
  • Jenkins, Dagan
  • Boldt, Karsten
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2025-03
Volume
24
Issue
3
Pages
100916
ISSN
1535-9476 (ISSN-L)
OpenAlex
W4406852503
Cited by
6
References
10
Citations by year
2026: 3 · 2025: 2 · 2023: 1
FWCI
2.94
Type
journal article
Language
en
Open access
Locations
  • Molecular & Cellular Proteomics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Bundesministerium für Bildung und Forschung (NDCiL FKZ 01EW2212)
  • European Commission Marie Sklodowska-Curie Actions (861329)
  • Wellcome Trust (210585/A/18/Z)
  • Eberhard Karls Universität Tübingen
  • Horizon 2020
  • Austrian Federal Ministry of Education Science and Research
  • H2020 Marie Skłodowska-Curie Actions
  • Tistou and Charlotte Kerstan Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
ciliopathies, IFT140, missense mutations, IFT-A complex, intraflagellar transport, genotype-phenotype correlation, protein-protein interaction, cilia assembly, Jeune syndrome, retinal dystrophy, compound heterozygosity, pathogenicity prediction, polymorphism
MeSH terms
Ciliopathies, Animals, Carrier Proteins, Cilia, Humans, Phenotype, Mutation, Missense, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review